Skip to content
Screener

Eikon Therapeutics, Inc. EIKN Enterprise value

Enterprise value at other companies

Gilead Sciences logo
Gilead SciencesGILD
$179.93B+17.5%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$2.8B+110%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1B+982%
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
-$13.45M-116%
Immunome logo
ImmunomeIMNM
$1.9B+470%
Erasca, Inc. logo
Erasca, Inc.ERAS
$5.03B+1,265%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M—
Total equity$550.7M+186%
Total assets$850.8M—

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$498.62M-36.3%

Returns & leverage

See full
Debt / equity0.5×—
Current ratio11.8×—

FAQ

What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.